Table II.
Parameters before and after 1 month of thyroxine treatment.
| Parameters | Before treatment (n=157) | 1 Month after treatment (n=157) |
|---|---|---|
| Male | 36 | 36 |
| Female | 121 | 121 |
| FT3 (pmol/l) | 2.01±0.73a | 5.19±0.92 |
| FT4 (pmol/l) | 5.38±2.33a | 19.44±4.30 |
| TSH (uIU/ml) | 86.65±43.50a | 7.27±14.61 |
| TC (mmol/l) | 6.96±1.29a | 5.19±1.10 |
| TG (mmol/l) | 2.25±1.40a | 1.63±1.05 |
| LDL-C (mmol/l) | 4.40±1.11a | 3.09±0.98 |
| HDL-C (mmol/l) | 2.69±12.80 | 1.40±0.52 |
FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid-stimulating hormone; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.
a
P<0.01 vs. after treatment, analyzed by independent samples t-test.